Skip to main content

Advertisement

SpringerLink
Log in

The surgical oncologist as a key translator of basic biology to patients with gastrointestinal cancer: Asking the right questions

  • SSO Clinical Award Lecture
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Steele G Jr, Cady B, eds.General surgical oncology. Philadelphia: WB Saunders, 1992.

    Google Scholar 

  2. Lotz MM, Andrews CW Jr, Steele GD Jr, et al. Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma.Proc Natl Acad Sci USA 1993;90:3466–70.

    CAS  PubMed  Google Scholar 

  3. Daneker GW, Jr, Piazza AJ, Steele GD Jr, Mercurio AM. Relationship between extracellular matrix interactions and degree of differentiation in human colon carcinoma cell lines.Cancer Res 1989;49:681–6.

    CAS  PubMed  Google Scholar 

  4. Daneker GW, Piazza AJ, Steele G Jr, Mercurio AM. The expression and membrane association of a cell surface marker in colorectal carcinoma cells is related to their degree of differentiation.Surg Forum 1988;32:440–2.

    Google Scholar 

  5. Daneker GW, Mercurio AM, Guerra L, et al. Laminin expression in colorectal carcinomas varying in degree of differentiation.Arch Surg 1987;122:1470–4.

    PubMed  Google Scholar 

  6. Lee EC, Woo HJ, Korzelius CA, et al. CBP-35 is the major cell surface laminin binding protein in colon carcinoma.Arch Surg 1991;126:1498–1502.

    CAS  PubMed  Google Scholar 

  7. Mafune K, Ravikumar TS, Wong JM, et al. Expression of a 32-kDa laminin-binding protein mRNA in human colon carcinoma correlates with disease progression.Cancer Res 1990;50:3888–91.

    CAS  PubMed  Google Scholar 

  8. Yow H, Wong JM, Chen HS, et al. Increased mRNA expression of a laminin-binding protein in human colon carcinoma: complete sequence of a full-length cDNA encoding the protein.Proc Natl Acad Sci USA 1988;85:6394–8.

    CAS  PubMed  Google Scholar 

  9. Lee EC, Lotz MM, Steele G Jr, Mercurio AM. The integrin a6B4 is a laminin receptor.J Cell Biol 1992;117:671–8.

    Article  CAS  PubMed  Google Scholar 

  10. Daneker GW, Guerra BS, Wolf B, et al. Laminin expression in colorectal carcinomas varying in degree of differentiation [Abstract].J Cell Biochem 1987;suppl 11D:107.

    Google Scholar 

  11. Breen E, Clarke A, Steele GD Jr, Mercurio AM. Poorly differentiated colon carcinoma cell lines deficient in α-catenin expression express high levels of surface E-caderin but lack Ca2+-dependent cell-cell adhesion.Cell Adhes Commun (in press).

  12. Salem RR, Wolf BC, Sears HF, et al. A cell surface glycoprotein expressed by colorectal carcinomas including poorly differentiated, noncarcinoembryonic antigen-producing colorectal tumors.Cancer Res 1988;48:7257–63.

    CAS  PubMed  Google Scholar 

  13. Salem RR, Bleday R, Daneker G, et al. Production and evaluation of a monoclonal antibody to non-CEA producing colorectal cancers.Surg Forum 1987;38:408–10.

    Google Scholar 

  14. Niles RM, Wilhelm SA, Steele G Jr, et al. Isolation and characterization of an undifferentiated human colon carcinoma cell line (MIP-101).Cancer Invest 1987;5:545–52.

    CAS  PubMed  Google Scholar 

  15. Bleday R, Thomas P, Litt K, et al. Production and characterization of two monoclonal antibodies to antigens on non-carcinoembryonic antigen (CEA)-secreting colorectal cell lines.Surg Forum 1986;37:383–5.

    Google Scholar 

  16. Bleday R, Song G, Dodson T, et al. Characterization of a new monoclonal antibody to a cell surface antigen on colorectal cancer and fetal gut tissues.Cancer 1986;57:433–40.

    CAS  PubMed  Google Scholar 

  17. Barnard GF, Bao S, Staniunas R, et al. Increased expression of human acidic ribosomal phosphoprotein PO mRNA in carcinomas of colonic and hepatocellular origin.Cancer Res 1992;52:3067–72.

    CAS  PubMed  Google Scholar 

  18. Barnard GF, Puder M, Staniunas RJ, et al. Ribosomal protein L37 MRNA expression is variable between human colonic and non-colonic cell lines and cloned human L37 has multiple potential sites of phosphorylation [Abstract].Gastroenterology 1992;102:A343.

    Google Scholar 

  19. Mori M, Barnard GF, Staniunas RJ, et al. Prothymosin-a MRNA expression correlates with that of c-myc in human colon cancer.Arch Surg 1993;8:2821–6.

    CAS  Google Scholar 

  20. Steele G Jr, Davis S, Yow H, Chen LB. Alteration of gene expression in human colon cancer: biological implications.Arch Surg 1990;125:493–7.

    CAS  PubMed  Google Scholar 

  21. Mafune K, Wong JM, Staniunas RJ, et al. Ubiquitin hybrid protein gene expression during human colon cancer progression.Arch Surg 1991;126:462–6.

    CAS  PubMed  Google Scholar 

  22. Weber T, Kramer R, Arceci R, et al. Expression of the MDR phenotype in colon cancer.Arch Surg (in press).

  23. Wolf BC, D'Emilia JC, Salem RR, et al. The detection of the tumor associated glycoprotein antigen (TAG-72) in premalignant lesions of the colon.J Natl Cancer Inst 1989;81:1913–7.

    CAS  PubMed  Google Scholar 

  24. D'Emilia J, Bulovas K, D'Ercole K, et al. Expression of the c-erbB-2 gene product (p185) at different stages of neoplastic progression in the colon.Oncogene 1989;4:1233–9.

    PubMed  Google Scholar 

  25. Wolf BC, Salem RR, Sears HF, et al. The expression of colorectal carcinoma-associated antigens in the normal colonic mucosa: an immunohistochemical analysis of regional distribution.Am J Pathol 1989;135:111–9.

    CAS  PubMed  Google Scholar 

  26. Wolf BC, Salem RR, Sears HF, et al. The expression of colorectal carcinoma-associated antigens in colonic polyps [Abstract].Gastroenterology 1989;96:A549.

    Google Scholar 

  27. Zamcheck N, Liu P, Thomas P, Steele G Jr. Search for useful biomarkers of pre- or early malignant colonic tumors.Prog Clin Biol Res 1988;279:251–75.

    CAS  PubMed  Google Scholar 

  28. Wagner HE, Thomas P, Wolf BC, et al. Inhibition of sialic acid incorporation prevents hepatic metastases.Arch Surg 1990;125:351–4.

    CAS  PubMed  Google Scholar 

  29. Heres T, Thomas P, Steele G Jr. The effects of biliary obstruction on transport of CEA and other glycoproteins from blood to bile.Gastroenterology 1986;90:1733.

    Google Scholar 

  30. Thomas P, Petrick AT, Toth CA, et al. Peptide sequence on carcinoembryonic antigen binds to a 80kD protein on Kupffer cells.Biochem Biophys Res Comm 1992;188:671–7.

    Article  CAS  PubMed  Google Scholar 

  31. Meterissian SH, Toth CA, Steele G Jr, Thomas P. Relationship between Kupffer cell attachment and hepatic metastases in colorectal cancer.Arch Surg (in press).

  32. Thomas P, Toth CA, Steele G Jr. Carcinoembryonic antigenbinding proteins from Kupffer cells. In: Wisse EW, Knook DL, McCuskey RS, eds.Cells of the hepatic sinusoid, vol. 3. Leiden, The Netherlands: Kupffer Cell Foundation, 1991:506–9.

    Google Scholar 

  33. Toth CA, Rapoza A, Zamcheck N, et al. Receptor-mediated endocytosis of carcinoembryonic antigen by rat alveolar macrophages in vitro.J Leukocyte Biol 1989;45:370–6.

    CAS  PubMed  Google Scholar 

  34. Toth CA, Rapoza A, Kowal A, et al. Receptor mediated endocytosis by human Kupffer cells.Biochem Soc Trans 1988;16:1027–8.

    CAS  Google Scholar 

  35. Toth CA, Thomas P, Rapoza A, et al. Carcinoma orosomucoid related antigen (CORA), a carcinoembryonic antigen (CEA) binding protein isolated from malignant ascites.FASEB J 1988;2:815.

    Google Scholar 

  36. Wagner HE, Steele G Jr, Thomas P. Experimentelle lebermetastasen von menschlichen kolonkarzinomen: Korrelation mit differenzierungsgrad und CEA-produktion.Helv Chir Acta 1992;58:759–61.

    CAS  PubMed  Google Scholar 

  37. Wagner HE, Toth CA, Steele G Jr, Thomas P. Metastatic potential of human colon cancer cell lines: relationship to cellular differentiation and carcinoembryonic antigen production.Clin Exp Metastasis 1992;10:25–31.

    CAS  PubMed  Google Scholar 

  38. Wagner HE, Thomas P, Wolf BC, et al. Characterization of the tumorigenic and metastatic potential of a poorly differentiated human colon cancer cell line.Invas Metast 1990;10:253–66.

    CAS  Google Scholar 

  39. Thomas P, Toth CA, Saini KS, et al. The structure, metabolism and function of the carcinoembryonic antigen gene family.Biochem Biophys Acta 1990;1032:177–89.

    CAS  PubMed  Google Scholar 

  40. Hostetter RB, Campbell DE, Chi K, et al. Carcinoembryonic antigen enhances metastatic potential of human colorectal carcinoma.Arch Surg 1990;125:300–4.

    CAS  PubMed  Google Scholar 

  41. Jessup JM, Petrick AJ, Toth CA, et al. Carcinoembryonic antigen: enhancement of liver colonization through retention of human colorectal carcinoma cells.Br J Cancer (in press).

  42. Ishii S, Ford R, Thomas P, et al. CD44 mediates adhesion of colorectal carcinoma to basement membrane and extracellular matrix.Surg Forum 1992;63:450–3.

    Google Scholar 

  43. Ishii S, Steele G Jr, Ford R, et al. Normal colonic epithelium adheres to carcinoembryonic antigen and Type IV collagen.Gastroenterology (in press).

  44. Deleted in proofs.

  45. Pories S, Greathead P, Steele G Jr, Summerhayes I. Expression of individual ras proteins in normal and neoplastic colon.Int J Oncol (in press).

  46. Pories S, Jaros K, Steele G Jr, et al. Oncogene-mediated transformation of fetal rat colon in vitro.Oncogene 1992;7:885–93.

    CAS  PubMed  Google Scholar 

  47. Weber T, Steele G Jr, Summerhayes I. Differential pp60c-src activity in well and poorly differentiated human colon carcinomas and cell lines.J Clin Invest 1992;90:815–21.

    CAS  PubMed  Google Scholar 

  48. Pories SE, Summerhayes IC, Steele GD. Oncogene mediated transformation: an in vitro model for colon carcinogenesis.Arch Surg 1991;126:1387–9.

    CAS  PubMed  Google Scholar 

  49. Wagner H, Steele GD, Summerhayes IC. Preneoplastic lesions induced by MYC and SRC oncogenes in reconstituted mouse bladder.Surgery 1990;108:146–53.

    CAS  PubMed  Google Scholar 

  50. D'Emilia J, Bulovas K, D'Ercole K, et al. Expression of the c-erbB-2 gene product (p185) at different stages of neoplastic progression in the colon.Oncogene 1989;4:1233–9.

    PubMed  Google Scholar 

  51. Joyce AD, Bulovas KM, Steele G Jr, Summerhayes IC. A new in vivo model to study metastasis in human bladder urothelium.Surg Forum 1988;32:695–7.

    Google Scholar 

  52. Andrews CW Jr, O'Hara CJ, Goldman H, et al. Sucrase-isomaltase expression in chronic ulcerative colitis and dysplasia.Human Pathol 1992;23:774–9.

    Google Scholar 

  53. Wiltz O, O'Hara CJ, Steele GD Jr, Mercurio AM. Expression of enzymatically active sucrase isomaltase is a ubiquitous property of colon adenocarcinoma.Gastroenterology 1991;100:1266–78.

    CAS  PubMed  Google Scholar 

  54. Wiltz O, O'Hara C, Mercurio AM, Steele GD Jr. Sucrase isomaltase marker associated with the progression of adenomatous polyps to adenocarcinomas of the colon.Surgery 1990;108:269–75.

    CAS  PubMed  Google Scholar 

  55. Smiley ST, Reers M, Mottola-Hartshorn C, et al. Intracellular heterogeneity in mitochondrial membrane potentials revealed by a j-aggregate-forming lipophilic cation JC-1.Proc Natl Acad Sci USA 1991;88:3671–5.

    CAS  PubMed  Google Scholar 

  56. Modica-Napolitano J, Steele G Jr, Chen LB. Aberrant mitochondria in two human colon carcinoma cell lines.Cancer Res 1989;49:3369–73.

    CAS  PubMed  Google Scholar 

  57. Weiss MJ, Wong FJ, Ha CS, et al. Dequalinium, a topical antimicrobial agent, displays anticarcinoma activity based on selective mitochondrial accumulation.Proc Natl Acad Sci USA 1987;84:5444–8.

    CAS  PubMed  Google Scholar 

  58. Bleday R, Weiss MJ, Salem RR, et al. Inhibition of rat colon tumor isograft growth with dequalinium chloride.Arch Surg 1986;121:1272–5.

    CAS  PubMed  Google Scholar 

  59. Steele GD Jr, Winchester DP, Menck HR, Murphy GP. National Cancer Data Base. Annual Review of Patient Care. Atlanta: American Cancer Society/American College of Surgeons Commission on Cancer, 1992.

    Google Scholar 

  60. Steele GD Jr, Winchester DP, Menck HR, Murphy GP. Clinical highlights from the National Cancer Data Base: 1993.CA 1993;43:71–82.

    PubMed  Google Scholar 

  61. Lindemann F, Schlimok G, Dirschedl P, et al. Prognostic significance of micrometastatic tumor cells in bone marrow of colorectal cancer patients.Lancet 1992;340:685–9.

    Article  CAS  PubMed  Google Scholar 

  62. Cote RJ, Rosen PP, Lesser ML, et al. Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases.J Clin Oncol 1991;9:1749–56.

    CAS  PubMed  Google Scholar 

  63. Liang P, Pardee AB. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction.Science 1992;257:967.

    CAS  PubMed  Google Scholar 

  64. Jessup JM, Gallick GE. The biology of colorectal carcinoma.Curr Prob Cancer 1992;16:265–327.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. From Harvard Medical School and the Department of Surgery, New England Deaconess Hospital, Boston, Massachusetts, USA

    Glenn Steele Jr. MD, PhD

Authors
  1. Glenn Steele Jr. MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Steele, G. The surgical oncologist as a key translator of basic biology to patients with gastrointestinal cancer: Asking the right questions. Annals of Surgical Oncology 1, 262–269 (1994). https://doi.org/10.1007/BF02303532

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02303532

Keywords

Search

Navigation